Asset Details
Do you wish to reserve the book?
Effects of Clonidine and Methylphenidate on Family Quality of Life in Attention-Deficit/Hyperactivity Disorder
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Effects of Clonidine and Methylphenidate on Family Quality of Life in Attention-Deficit/Hyperactivity Disorder
Do you wish to request the book?
Effects of Clonidine and Methylphenidate on Family Quality of Life in Attention-Deficit/Hyperactivity Disorder
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Effects of Clonidine and Methylphenidate on Family Quality of Life in Attention-Deficit/Hyperactivity Disorder
2009
Overview
Objective:
The aim of this study was to determine the effect on family quality of life (QOL) of clonidine (CLON) and methylphenidate (MPH), used alone and in combination, in treating attention-deficit/hyperactivity disorder (ADHD).
Methods:
Two proxy QOL measures were used in a multicenter, double-blind, placebo-controlled 16-week trial of 122 children, ages 7–12 years, with ADHD. Children were randomized to one of four groups in which they received MPH, CLON, a combination of drugs, or placebo. QOL was measured with the Daily Hassles Scale and the Impact on Family Scale at baseline and at 16 weeks.
Results:
In a general linear model repeated measures analysis, treatment groups improved over a 16-week period compared to placebo for Daily Hassles and Impact on Family, as well as in symptoms measured by the ADHD Rating Scale. QOL measures correlated moderately with efficacy and symptom measures.
Conclusion:
This study provides evidence that measures of QOL for the family are sensitive to pharmacological treatment of ADHD. The correlation pattern of the QOL measures with symptom and efficacy variables supported family QOL as a related but separate construct. Clonidine for Attention-Deficit/Hyperactivity Disorder Treatment Study (CAT) Trial Registry Name: Clinicaltrials.gov; ID Number, NCT00031395; URL, http://clinicaltrials.gov/ct/show/NCT00031395?order=8/.
Publisher
SAGE Publications,Mary Ann Liebert, Inc
Subject
Adrenergic alpha-Agonists - therapeutic use
/ Attention Deficit Disorder with Hyperactivity - drug therapy
/ Attention deficit hyperactivity disorder
/ Central Nervous System Stimulants - therapeutic use
/ Child
/ Complications and side effects
/ Female
/ Humans
/ Male
/ Methylphenidate - therapeutic use
/ Methylphenidate hydrochloride
/ Original
We currently cannot retrieve any items related to this title. Kindly check back at a later time.